SANTOS DA SILVA JORGE (Chief Executive Officer) sold 3.6% of their position (102.22K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $2.05M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/13/2026ACC: 0001213900-26-077564
DirectorOfficer· Chief Executive Officer
Since Apr 2022
-102.22K
Net shares
Net seller
$2.05M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
102.22K disposed
Non-Derivative Transactions2
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−33.94K
Price / share
$20.01
Trade value
$679.06K
% of position
1.2%
7/9/2026
2.88M→2.84M
Class A ordinary shares, par value $0.0001 per share
Direct
Shares
−68.29K
Price / share
$20.02
Trade value
$1.37M
% of position
2.4%
7/10/2026
2.84M→2.77M
Total
Net shares
−102.22K
Net value
-$2.05M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Direct | 7/9/2026 | S · Sale | −33.94K | $20.01 | $679.06K | 1.2% | 2.88M | 2.84M |
| Class A ordinary shares, par value $0.0001 per share Direct | 7/10/2026 | S · Sale | −68.29K | $20.02 | $1.37M | 2.4% | 2.84M | 2.77M |
| Total | −102.22K | -$2.05M | ||||||
Derivative Transactions0
No derivative transactions reported